Track the Creo Medical Group plc share price and the full directors' dealings record of the company, a publicly traded company based in United Kingdom. Shares are listed on the UK market, under the authority of RNS (LSE). Market capitalisation: €66.2m. The latest transaction was filed on 2 June 2025 (Purchase). Among the most active insiders: Richard Rees. Every trade is openly available.
8
Insider Decl.
n/a
Thresholds
n/a
6 ops.
Buy Volume
n/a
2 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Creo Medical Group plc Strong Buy (bullish), based on 2 analysts. Average price target: £55.00.
Fundamental score
Ranked 16,082 of 29,064 companies
49.0
score / 100
Value
45
Quality
54
FCF yld-30%
Earn yld8.0%
EV/EBITDA·
ROE-77%
Gross mgn40%
Net mgn88%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Creo Medical Group plc es una empresa centrada en el desarrollo de tecnologías médicas innovadoras para el tratamiento del cáncer. Su objetivo es crear dispositivos que mejoren los resultados de los pacientes a través de enfoques menos invasivos.